Lisuride in the treatment of parkinsonism.

  title={Lisuride in the treatment of parkinsonism.},
  author={Robert J. McDonald and Reinhard Horowski},
  journal={European neurology},
  volume={22 4},
Lisuride is a new effective antiparkinson agent that is useful in the management of patients in an advanced stage of parkinsonism where levodopa therapy is no longer sufficient and/or limited by 'wearing off' reactions. Patients with these problems usually respond favorably to 1.5-4.5 mg of lisuride daily provided the daily dose is built up gradually over a period of 4-8 weeks. All the clinical features of parkinsonism may be improved and the daily dose of levodopa may be reduced by 30-40%. In… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…